Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A gut microbial signature for combination immune checkpoint blockade across cancer types
Ashray Gunjur, Yan Shao, Timothy Rozday, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 797-809
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 15
The intestinal microbiome and metabolome discern disease severity in cytotoxic T-lymphocyte-associated protein 4 deficiency
Prabha Chandrasekaran, Máté Krausz, Yu Han, et al.
Microbiome (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors
Marius Bredon, Camille Danne, Hang‐Phuong Pham, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis
Xinpei Li, Shijie Shang, Meng Wu, et al.
Cancer Letters (2024) Vol. 598, pp. 217096-217096
Closed Access | Times Cited: 9
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Diwakar Davar, Robert M. Morrison, Amiran Dzutsev, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1898-1918.e12
Open Access | Times Cited: 7
Long-distance microbial mechanisms impacting cancer immunosurveillance
Laurence Zitvogel, Marine Fidelle, Guido Kroemer
Immunity (2024) Vol. 57, Iss. 9, pp. 2013-2029
Closed Access | Times Cited: 6
Community characteristics and relationship between gut microbiota and intratumoral microbiota in hepatocellular carcinoma
Hung-Wen Lin, Zhanshan Ma, Jin Li, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy
Maruhen Amir Datsch Silveira, Richard R. Rodrigues, Giorgio Trinchieri
Gastroenterology Clinics of North America (2025)
Closed Access
Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses
Xiaoqiang Zhu, Muni Hu, Xiaowen Huang, et al.
Cell Metabolism (2025)
Closed Access
The gut microbiota in spondyloarthritis: an update
Valeria Ríos Rodríguez, Morgan Essex, Denis Poddubnyy
Current Opinion in Rheumatology (2025)
Closed Access
Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma
Zheng Yijia, Xiaoyu Li, Li‐Na Ma, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Enriched pathways in the gut microbiome predict response to immune checkpoint inhibitor treatment across demographic regions and various cancer types
Xunhui Cai, Jennifer Y. Cho, Lijun Chen, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112162-112162
Open Access
Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite
Troels Holger Vaaben, Ditte Olsen Lützhøft, Andreas Koulouktsis, et al.
EMBO Reports (2025)
Open Access
Hallmarks of artificial intelligence contributions to precision oncology
Tiangen Chang, Seongyong Park, Alejandro A. Schäffer, et al.
Nature Cancer (2025)
Closed Access
Gut microbiota in colorectal cancer: a review of its influence on tumor immune surveillance and therapeutic response
Chunlei Zhang, Yong Wang, Lei Cheng, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Prioritizing gut microbial SNPs linked to immunotherapy outcomes in NSCLC patients by integrative bioinformatics analysis
Muhammad Faheem Raziq, N. A. Khan, Haseeb Manzoor, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
Stephen L. Wang, Timothy A. Chan
Cancer Cell (2025)
Closed Access
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers
Roxanne Birebent, Damien Drubay, Carolina Alves Costa Silva, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Advancements in the Application of the Intersection of Medicine and Engineering in Cancer Research
Haitao Chen, Guan-Meng Zhang, Yuping Qian, et al.
(2025)
Open Access
Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity
Kai Trepka, Wesley Kidder, Than S. Kyaw, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 794
Closed Access
Faecal transplants can treat some cancers — but probably won’t ever be widely used
Liam Drew
Nature (2024)
Closed Access | Times Cited: 3
Exploring the frontier of microbiome biomarker discovery with artificial intelligence
Liwen Xiao, Fangqing Zhao
National Science Review (2024) Vol. 11, Iss. 11
Open Access | Times Cited: 3
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
Eléonora De Martin, Claudia Angela Maria Fulgenzi, Ciro Celsa, et al.
Gut (2024), pp. gutjnl-332125
Closed Access | Times Cited: 3
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients
Angeli D. Macandog, Carlotta Catozzi, Mariaelena Capone, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 11, pp. 2004-2018.e9
Open Access | Times Cited: 2
Narrative Review: Advancing Dysbiosis Treatment in Onco-Hematology with Microbiome-Based Therapeutic Approach
Salomé Biennier, Mathieu Fontaine, Aurore Duquenoy, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2256-2256
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top